Olfactory Hallucinations without Clinical Motor Activity: A Comparison of Unirhinal with Birhinal Phantosmia

Abstract

Olfactory hallucinations without subsequent myoclonic activity have not been well characterized or understood. Herein we describe, in a retrospective study, two major forms of olfactory hallucinations labeled phantosmias: one, unirhinal, the other, birhinal. To describe these disorders we performed several procedures to elucidate similarities and differences between these processes. From 1272, patients evaluated for taste and smell dysfunction at The Taste and Smell Clinic, Washington, DC with clinical history, neurological and otolaryngological examinations, evaluations of taste and smell function, EEG and neuroradiological studies 40 exhibited cyclic unirhinal phantosmia (CUP) usually without hyposmia whereas 88 exhibited non-cyclic birhinal phantosmia with associated symptomology (BPAS) with hyposmia. Patients with CUP developed phantosmia spontaneously or after laughing, coughing or shouting initially with spontaneous inhibition and subsequently with Valsalva maneuvers, sleep or nasal water inhalation; they had frequent EEG changes usually ipsilateral sharp waves. Patients with BPAS developed phantosmia secondary to several clinical events usually after hyposmia onset with few EEG changes; their phantosmia could not be initiated or inhibited by any physiological maneuver. CUP is uncommonly encountered and represents a newly defined clinical syndrome. BPAS is commonly encountered, has been observed previously but has not been clearly defined. Mechanisms responsible for phantosmia in each group were related to decreased gamma-aminobutyric acid (GABA) activity in specific brain regions. Treatment which activated brain GABA inhibited phantosmia in both groups.

Olfactory hallucinations as primary symptom for ischemia in the right posterior insula

“…Mostly, olfactory hallucinations occur during the clinical course of diseases in patients with anosmia or severe hyposmia following nerve degeneration (e.g. patients with traumatic head injury or Parkinson disease), or in patients with pathological hyperactivation in the olfactory system such as migraines or temporal lobe epilepsy [6]. The closest to our case are two reports on olfactory hallucinations in the acute and subacute …”

The role of surgery in the management of phantosmia

“…Phantosmia is the qualitative disorder of olfaction characterized by the perception of odor, usually unpleasant, when there are no odorants present . It may be described as cacosmic (rotten, decayed, fecal), torquosmic (burned, metallic, chemical‐like), or mixed . Phantosmia is a relatively uncommon disorder of olfaction and represents around 10% to 20% of olfactory disorders among those complaining of olfactory dysfunction .…”

Phantosmia and Migraine With and Without Headache

“…Deviant olfactory experiences in an initially nonpsychotic group of college students was interestingly found to predict the development of clinical psychosis at a 10‐year reevaluation . Olfactory hallucination has also been described in depression (19–33%) and in up to 10% of non‐demented Parkinson's disease patients, though prevalence is less (5%) in those without accompanying visual and auditory hallucination . In temporal lobe epilepsy, estimated prevalence ranges from 0.6 to 30% .…”

“…In temporal lobe epilepsy, estimated prevalence ranges from 0.6 to 30% . A higher prevalence has been reported in those with head injury and those with decreased smell and taste acuity in up to 40–60% of patients …”

“…Histopathological studies also demonstrated decreased number of neurons, greater ratio of immature to mature neurons and disordered growth of olfactory axons . A combination of peripheral hypersensitivity, endogenous loss of inhibitory GABAergic neurons, and possibly estrogen may play a role in the pathogenesis of phantosmia . Ultimately, abnormal signals arise from primary olfactory neurons, which then trigger a central process …”